China
· Delayed Price · Currency is CNY Pharmaron Beijing Company Description
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides drug research and development, and production services to the life sciences industry in North America, Europe, Japan, Mainland China, and internationally.
The company offers laboratory chemistry services, including medicinal and synthetic chemistry, chemistry for new modalities, radiolabelling and radiosynthesis, analytical and purification chemistry, DNA-encoded libraries, cheminformatics, and computer-aided drug design; bioscience services, such as structural biology, in vitro biology, DMPK, in vivo pharmacology, and compound management services; chemistry, manufacturing, and controls services.
It also provides clinical development services, including integrated radio labelled science, clinical development, and clinical trial recruitment services; safety assessment, integrated drug discovery, and bioanalysis services; and biologics and cell and gene therapy services, comprising biologics laboratory, biologics CDMO, cell and gene therapy laboratory, and gene therapy CDMO services.
Pharmaron Beijing Co., Ltd. was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
| Country | China |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 20,295 |
| CEO | Boliang Lou |
Contact Details
Address: Building 1 Beijing, 100176 China | |
| Website | pharmaron.com |
Stock Details
| Ticker Symbol | 300759 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003JW4 |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Dr. Boliang Lou Ph.D. | Chairman and Chief Executive Officer |
| Xiaoqiang Lou EMBA | Co-Founder, President, Chief Operating Officer and Executive Director |
| Bei Zheng M.A, M.A. | Executive Vice President and Executive Director |
| Shing Chung Li C.F.A., CPA | Chief Financial Officer and Secretary of the Board |
| Dr. Hua Yang Ph.D. | Chief Scientific Officer and Deputy Manager |
| Dr. Connie Sun Ph.D. | Senior Vice President and Global Head of Business Development of Small Molecules |
| Celina Zhong M.B.A., MBA | Senior Vice President of Human Resources |
| Katherine Lee M.B.A., MBA | Chief Business Officer |
| Stephen Lewinton | Senior Vice President of UK Operations |
| Dr. Jingqi Huang | Senior Vice President of In Vivo Pharmacology |